4//SEC Filing
Henrich Jill 4
Accession 0000905148-24-000111
CIK 0001604464other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:40 PM ET
Size
5.3 KB
Accession
0000905148-24-000111
Insider Transaction Report
Form 4
Henrich Jill
EVP, Chief Regulatory Officer
Transactions
- Award
Common Stock
2024-01-08+450,000→ 558,880 total
Footnotes (2)
- [F1]These restricted stock units vest as to 1/8th of the total number of shares (rounded down to the next whole number of shares) on the second Quarterly Vesting Date (as defined below) following January 8, 2024, and as to 1/8th of the total number of shares (rounded down to the next whole number of shares) on the next seven Quarterly Vesting Dates, such that all of the shares shall be vested on the last Quarterly Vesting Date, subject to the reporting person's continuous service. "Quarterly Vesting Date" means March 1, May 15, August 15, and November 15 of each year, provided that if such date falls on a weekend or holiday, the Quarterly Vesting Date shall be the first business day after such date.
- [F2]Includes 4,456 shares purchased under the Issuer's Employee Stock Purchase Plan on November 30, 2023.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001978096
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 4:40 PM ET
- Size
- 5.3 KB